Skip to main content
. 2018 Nov 21;11:8239–8250. doi: 10.2147/OTT.S152514

Figure 2.

Figure 2

CT imaging of hyper-progression.

Notes: (A, C) Representative CT imaging before nivolumab treatment. (B, D) CT evaluation after three cycles of nivolumab showed remarkable enlargement of liver metastatic lesions, indicating a fast cancer progression. White line shows margins of liver metastases.